UniProt ID | CSEN_HUMAN | |
---|---|---|
UniProt AC | Q9Y2W7 | |
Protein Name | Calsenilin | |
Gene Name | KCNIP3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 256 | |
Subcellular Localization |
Cytoplasm . Cell membrane Lipid-anchor. Endoplasmic reticulum . Golgi apparatus . Nucleus . Also membrane-bound, associated with the plasma membrane (PubMed:15485870). In the presence of PSEN2 associated with the endoplasmic reticulum and Golgi. Th |
|
Protein Description | Calcium-dependent transcriptional repressor that binds to the DRE element of genes including PDYN and FOS. Affinity for DNA is reduced upon binding to calcium and enhanced by binding to magnesium. Seems to be involved in nociception (By similarity).; Regulatory subunit of Kv4/D (Shal)-type voltage-gated rapidly inactivating A-type potassium channels, such as KCND2/Kv4.2 and KCND3/Kv4.3. Modulates channel expression at the cell membrane, gating characteristics, inactivation kinetics and rate of recovery from inactivation in a calcium-dependent and isoform-specific manner.; May play a role in the regulation of PSEN2 proteolytic processing and apoptosis. Together with PSEN2 involved in modulation of amyloid-beta formation.. | |
Protein Sequence | MQPAKEVTKASDGSLLGDLGHTPLSKKEGIKWQRPRLSRQALMRCCLVKWILSSTAPQGSDSSDSELELSTVRHQPEGLDQLQAQTKFTKKELQSLYRGFKNECPTGLVDEDTFKLIYAQFFPQGDATTYAHFLFNAFDADGNGAIHFEDFVVGLSILLRGTVHEKLKWAFNLYDINKDGYITKEEMLAIMKSIYDMMGRHTYPILREDAPAEHVERFFEKMDRNQDGVVTIEEFLEACQKDENIMSSMQLFENVI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
8 | Phosphorylation | MQPAKEVTKASDGSL CCCCHHCCCCCCCCC | 23.22 | 22115753 | |
11 | Phosphorylation | AKEVTKASDGSLLGD CHHCCCCCCCCCCCC | 44.02 | 22115753 | |
14 | Phosphorylation | VTKASDGSLLGDLGH CCCCCCCCCCCCCCC | 25.97 | 22115753 | |
22 | Phosphorylation | LLGDLGHTPLSKKEG CCCCCCCCCCCHHCC | 24.91 | 26091039 | |
25 | Phosphorylation | DLGHTPLSKKEGIKW CCCCCCCCHHCCCCC | 42.77 | 22115753 | |
26 | Sumoylation | LGHTPLSKKEGIKWQ CCCCCCCHHCCCCCC | 63.63 | - | |
26 | Sumoylation | LGHTPLSKKEGIKWQ CCCCCCCHHCCCCCC | 63.63 | 21070824 | |
45 | S-palmitoylation | SRQALMRCCLVKWIL HHHHHHHHHHHHHHH | 1.00 | - | |
46 | S-palmitoylation | RQALMRCCLVKWILS HHHHHHHHHHHHHHH | 3.27 | - | |
60 | Phosphorylation | SSTAPQGSDSSDSEL HCCCCCCCCCCCCCE | 29.13 | - | |
63 | Phosphorylation | APQGSDSSDSELELS CCCCCCCCCCCEEHH | 50.58 | 16112838 | |
86 | Phosphorylation | LDQLQAQTKFTKKEL HHHHHHHCCCCHHHH | 31.01 | 29083192 | |
89 | Phosphorylation | LQAQTKFTKKELQSL HHHHCCCCHHHHHHH | 42.64 | 29083192 | |
90 | Sumoylation | QAQTKFTKKELQSLY HHHCCCCHHHHHHHH | 47.59 | 21070824 | |
90 | Sumoylation | QAQTKFTKKELQSLY HHHCCCCHHHHHHHH | 47.59 | - | |
95 | Phosphorylation | FTKKELQSLYRGFKN CCHHHHHHHHHHHCC | 39.74 | 17102134 | |
156 | Phosphorylation | EDFVVGLSILLRGTV HHHHHHHHHHHHCCH | 12.78 | 24719451 | |
174 | Phosphorylation | LKWAFNLYDINKDGY HHHHHHHCCCCCCCC | 18.84 | - | |
241 | Sumoylation | EFLEACQKDENIMSS HHHHHHHCCCCHHHH | 67.88 | - |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
63 | S | Phosphorylation |
| 12837631 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CSEN_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CD177_HUMAN | CD177 | physical | 16189514 | |
PSN2_HUMAN | PSEN2 | physical | 9771752 | |
PSN1_HUMAN | PSEN1 | physical | 9771752 | |
CREM_HUMAN | CREM | physical | 11094064 | |
PSN1_HUMAN | PSEN1 | physical | 10854253 | |
CREB1_HUMAN | CREB1 | physical | 12198160 | |
PHS2_HUMAN | PCBD2 | physical | 20211142 | |
UBC9_HUMAN | UBE2I | physical | 21070824 | |
GRK6_HUMAN | GRK6 | physical | 17102134 | |
ARBK1_HUMAN | ADRBK1 | physical | 17102134 | |
CSEN_HUMAN | KCNIP3 | physical | 17102134 | |
CLN3_HUMAN | CLN3 | physical | 17189291 | |
KCND2_HUMAN | KCND2 | physical | 23692269 | |
CD177_HUMAN | CD177 | physical | 25416956 | |
MAVS_HUMAN | MAVS | physical | 25416956 | |
CTBP1_HUMAN | CTBP1 | physical | 16787403 | |
CTBP2_HUMAN | CTBP2 | physical | 16787403 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...